Revenue is a critical indicator of a company's financial health and performance. A year-over-year decrease in revenue is generally perceived negatively by investors and can lead to a decline in stock price. Given that this is a significant drop in revenue for Sutro Biopharma, it is likely to have a negative impact on investor sentiment and the stock's short-term performance.